Clinical significance of cytogenetic findings at diagnosis and in remission in childhood and adult acute lymphoblastic leukemia: experience from India.

[1]  International System for Human Cytogenetic Nomenclature , 2020, Definitions.

[2]  S. Richards,et al.  Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X , 1997, British journal of haematology.

[3]  Hall,et al.  Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA , 1997, British journal of haematology.

[4]  H. Cavé,et al.  Delineation of a 6 cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal arm , 1997, Leukemia.

[5]  Y. Lau,et al.  Cytogenetics and immunophenotypes of childhood acute lymphoblastic leukemia in Hong Kong. , 1994, Cancer genetics and cytogenetics.

[6]  M. Santibanez-Koref,et al.  Deletion of a common region on the long arm of chromosome 6 in acute lymphoblastic leukaemia , 1994, Genes, chromosomes & cancer.

[7]  K Offit,et al.  6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. , 1993, Blood.

[8]  S. Raimondi.  Current Status of Cytogenetic Research in Childhood Acute Lymphoblastic Leukemia , 1993 .

[9]  G. Tricot,et al.  Interphase in situ hybridization reveals minimal residual disease in early remission and return of the diagnostic clone in karyotypically normal relapse of acute lymphoblastic leukemia. , 1993, Leukemia.

[10]  J. Rowley,et al.  Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Pedersen‐Bjergaard,et al.  Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II [letter] , 1991 .

[12]  J. Craig,et al.  Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. , 1991, Leukemia.

[13]  J. Shuster,et al.  Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1991, Blood.

[14]  F. Behm,et al.  Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy , 1991, The Lancet.

[15]  P. Taillon-Miller,et al.  Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Estey,et al.  The importance of cytogenetic studies in adult acute lymphocytic leukemia. , 1990, The American journal of medicine.

[17]  F. Behm,et al.  Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. , 1990, Blood.

[18]  C. Pui,et al.  Biology and Clinical Significance of Cytogenetic Abnormalities in Childhood Acute Lymphoblastic Leukemia , 1990 .

[19]  John R.W. Yates,et al.  Human Gene Mapping 10 , 1990 .

[20]  F. Behm,et al.  Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. , 1989, The New England journal of medicine.

[21]  O. Taboureau,et al.  Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) excluding L3 , 1989, Hematological oncology.

[22]  S. Richards,et al.  Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long‐term follow‐up , 1989, British journal of haematology.

[23]  F. Behm,et al.  Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. , 1989, Blood.

[24]  L. Secker-Walker,et al.  Detection of the chromosomally abnormal clone in acute lymphoblastic leukemia. , 1986, Cancer genetics and cytogenetics.

[25]  S. Nakazawa,et al.  Clinical and hematologic characteristics in acute leukemia with 11q23 translocations. , 1986, Blood.

[26]  C. Berard,et al.  Presence of clonal chromosome abnormalities in virtually all cases of acute lymphoblastic leukemia. , 1985, The New England journal of medicine.

[27]  N. Heerema,et al.  Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia. , 1985, Cancer genetics and cytogenetics.

[28]  J. Yunis,et al.  New chromosome techniques in the study of human neoplasia. , 1981, Human pathology.

[29]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[30]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[31]  C. Rizzi.  Statistical Methods , 2020, Springer Theses.

[32]  Y. Akao,et al.  Relationship of the human protooncogene CBL2 on 11q23 to the t(4;11), t(11;22), and t(11;14) breakpoints. , 1991, Cytogenetics and cell genetics.

[33]  F. Behm,et al.  Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Walker,et al.  Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. , 1986, Blood.

[35]  J. Whang‐Peng.  Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia , 1981 .

[36]  D. Cox.  Regression Models and Life-Tables , 1972 .